Drug recall · October 1, 2014
Rifampin for Injection USP recall
Why: Failed Impurity/Degradation Specification; high out of specification result for 23 transacetyl impurity at the 22 month stability time point
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Rifampin for Injection USP, 600 mg*/vial (Sterile), supplied in sterile glass vials, Rx only For IV Infusion only, individually boxed, Mfd. for: Akorn, Inc., Lake Forest, IL --- NDC 17478-151-42
- Lots / codes
Lot: 12RIF4A, Expiration Date: 9/30/2014
- Quantity
- 5,539 vials
- Company
- Akorn, Inc., Lake Forest, IL
- Distribution
- Nationwide
- Initiated
- August 5, 2014 · Voluntary: Firm initiated
- Classified
- September 22, 2014
- Reported
- October 1, 2014
- Ended
- May 21, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Rifampin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.